Andrew C. Hooker

Andrew C. Hooker

Uppsala Universitet

H-index: 28

Europe-Sweden

About Andrew C. Hooker

Andrew C. Hooker, With an exceptional h-index of 28 and a recent h-index of 17 (since 2020), a distinguished researcher at Uppsala Universitet, specializes in the field of Optimal Design, Nonlinear Mixed Effect Models, Pharmacometrics.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA

Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV

Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: summary of workshop

Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials

Thanks to our Reviewers of 2022!

How to analyze continuous and discrete repeated measures in small-sample cross-over trials?

A neutral comparison of statistical methods for time-to-event analyses under non-proportional hazards

Generation and application of avatars in pharmacometric modelling

Andrew C. Hooker Information

University

Position

Associate Professor of Pharmacometrics

Citations(all)

5019

Citations(since 2020)

2172

Cited By

3876

hIndex(all)

28

hIndex(since 2020)

17

i10Index(all)

55

i10Index(since 2020)

28

Email

University Profile Page

Uppsala Universitet

Google Scholar

View Google Scholar Profile

Andrew C. Hooker Skills & Research Interests

Optimal Design

Nonlinear Mixed Effect Models

Pharmacometrics

Top articles of Andrew C. Hooker

Title

Journal

Author(s)

Publication Date

The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA

The AAPS Journal

Lanyan Fang

Yuqing Gong

Andrew C Hooker

Viera Lukacova

Amin Rostami-Hodjegan

...

2024/2/27

Optimizing the design of a pharmacokinetic trial to evaluate the dosing scheme of a novel tuberculosis drug in children living with or without HIV

CPT: Pharmacometrics & Systems Pharmacology

Grace Montepiedra

Elin M Svensson

Weng Kee Wong

Andrew C Hooker

2024/2

Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: summary of workshop

Yuqing Gong

Peijue Zhang

Miyoung Yoon

Hao Zhu

Ameya Kohojkar

...

2023/5

Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials

Orphanet Journal of Rare Diseases

Martin Geroldinger

Johan Verbeeck

Andrew C Hooker

Konstantin E Thiel

Geert Molenberghs

...

2023/12/19

Thanks to our Reviewers of 2022!

Journal of Pharmacokinetics and Pharmacodynamics

Leon Aarons

Felix Agbo

Karel Allegaert

Teodor M Atanackovic

Rebecca Baillie

...

2023

How to analyze continuous and discrete repeated measures in small-sample cross-over trials?

Biometrics

Johan Verbeeck

Martin Geroldinger

Konstantin Thiel

Andrew Craig Hooker

Sebastian Ueckert

...

2023/12

A neutral comparison of statistical methods for time-to-event analyses under non-proportional hazards

arXiv preprint arXiv:2310.05622

Florian Klinglmüller

Tobias Fellinger

Franz König

Tim Friede

Andrew C Hooker

...

2023/10/9

Generation and application of avatars in pharmacometric modelling

Journal of Pharmacokinetics and Pharmacodynamics

Estelle Chasseloup

Andrew C Hooker

Mats O Karlsson

2023/10

Methods for non-proportional hazards in clinical trials: A systematic review<? show [AQ ID= GQ5 POS= 12pt]?><? show [AQ ID= GQ4]?><? show [AQ ID= GQ2 POS=--12pt]?>

Maximilian Bardo

Cynthia Huber

Norbert Benda

Jonas Brugger

Tobias Fellinger

...

2023/6/29

Pharmacometrics meets statistics—A synergy for modern drug development

CPT: Pharmacometrics & Systems Pharmacology

Yevgen Ryeznik

Oleksandr Sverdlov

Elin M Svensson

Grace Montepiedra

Andrew C Hooker

...

2021/10

Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

The AAPS Journal

Yassine Kamal Lyauk

Daniël M Jonker

Andrew C Hooker

Trine Meldgaard Lund

Mats O Karlsson

2021/3

Tutorial for $ DESIGN in NONMEM: Clinical trial evaluation and optimization

CPT: pharmacometrics & systems pharmacology

Robert J Bauer

Andrew C Hooker

France Mentre

2021/12

Model‐Informed Drug Development for Long‐Acting Injectable Products: Summary of American College of Clinical Pharmacology Symposium.

Clinical Pharmacology in Drug Development

Satish Sharan

Lanyan Fang

Viera Lukacova

Xiaomei Chen

Andrew C Hooker

...

2021/3/1

Metaheuristics for pharmacometrics

Seongho Kim

Andrew C Hooker

Yu Shi

Grace Hyun J Kim

Weng Kee Wong

2021/11

Public workshop summary report on fiscal year 2021 generic drug regulatory science initiatives: data analysis and model‐based bioequivalence

Jieon Lee

Yuqing Gong

Sid Bhoopathy

Charles E DiLiberti

Andrew C Hooker

...

2021/11

Saddle-reset for robust parameter estimation and identifiability analysis of nonlinear mixed effects models

The AAPS Journal

Henrik Bjugård Nyberg

Andrew C Hooker

Robert J Bauer

Yasunori Aoki

2020/7

Population pharmacokinetics and dosing of ethionamide in children with tuberculosis

Antimicrobial Agents and Chemotherapy

Henrik Bjugård Nyberg

Heather R Draper

Anthony J Garcia-Prats

Stephanie Thee

Adrie Bekker

...

2020/2/21

Item response theory modeling of the International Prostate Symptom Score in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia

The AAPS journal

Yassine Kamal Lyauk

Daniël M Jonker

Trine Meldgaard Lund

Andrew C Hooker

Mats O Karlsson

2020/9

See List of Professors in Andrew C. Hooker University(Uppsala Universitet)

Co-Authors

H-index: 88
Chun Yuan

Chun Yuan

University of Washington

H-index: 80
Mats Karlsson

Mats Karlsson

Uppsala Universitet

H-index: 15
Joakim Nyberg

Joakim Nyberg

Uppsala Universitet

H-index: 10
Sebastian Ueckert

Sebastian Ueckert

Uppsala Universitet

academic-engine